US General Surgical Devices Market Size
|Study Period||2018 - 2028|
|Base Year For Estimation||2022|
|Forecast Data Period||2023 - 2028|
|Historical Data Period||2018 - 2021|
*Disclaimer: Major Players sorted in no particular order
Need a report that reflects how COVID-19 has impacted this market and its growth?
US General Surgical Devices Market Analysis
The United States General Surgical Devices Market is expected to register a CAGR of 6.1% during the forecast period.
The COVID-19 pandemic significantly impacted surgical practice ranging from workforce and staff shortage, procedural prioritization, viral transmission risk, changes to perioperative practice, and ways of working alongside the impact on surgical education and training. The volume of surgeries significantly declined during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries. According to a research article published in Jama Network in December 2021, a 48.0% decrease in total surgical procedure volume was reported immediately after the March 2020 recommendation to cancel elective surgical procedures. Furthermore, according to another article published in the Journal of Surgical Research in June 2021, there was a 91% reduction from baseline in the number of elective surgeries performed, allowing 78% of surgical ICU beds to be available for COVID-19 patients. Thus, the United States general surgical devices market has been significantly impacted by COVID-19.
Factors like the increasing demand for minimally invasive devices and the growing cases of injuries and accidents are propelling the market growth. Minimally invasive surgeries (MIS) cause less post-operative pain, and hence, patients receive smaller dosages of painkillers. As minimal cuts or stitches are involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently. An increasing number of product launches for minimally invasive surgeries are anticipated to drive the market's growth. For instance, in September 2021, Medtronic PLC launched a minimally invasive spine surgery ecosystem to combine spinal implants, biologics, navigation, robotics, and AI-powered data for surgeons and patients. This included Catalyft PL and PL40, Space-D Access System, and Accelerate Graft Delivery System with Grafton DBF. The benefits of minimally invasive surgeries create high demand for these devices.
Moreover, the increased prevalence of chronic diseases has also promoted the demand for surgical devices in various surgeries, such as cardiovascular, orthopedic, and plastic surgeries, driving the market growth. According to the article "Trauma of Major Surgery" published in the NCBI in July 2020, around 40 to 50 million major surgeries were performed annually in the United States. Thus, increasing surgeries are also anticipated to drive the market's growth.
Thus, the increasing demand for minimally invasive surgical devices and the rising burden of chronic diseases will likely drive the market growth.
US General Surgical Devices Industry Segmentation
As per the report's scope, surgical devices serve a specific purpose during surgery. Typically, surgical devices have generic use, while some specific tools are designed for specific procedures or surgeries. The United States General Surgical Devices Market is Segmented by Product (Handheld Devices, Laparoscopic Devices, Electrosurgical Devices, Wound Closure Devices, Trocars and Access Devices, And Other Products) and Application (Gynecology And Urology, Cardiology, Orthopedic, Neurology, And Other Applications). The Report Offers the Value (In USD Million) for the Above Segments.
|Electro Surgical Devices|
|Wound Closure Devices|
|Trocars and Access Devices|
|Gynecology and Urology|
US General Surgical Devices Market Trends
Laparoscopic Devices is Expected to have a Significant Share in the Market
Laparoscopy is a type of surgery in which small incisions are made in the body. A laparoscope and other instruments are used for diagnosis and treatment without making a large incision. Compared to traditional open surgery, laparoscopic procedures often result in less pain, a shorter recovery, and less scarring. The increasing number of product approvals and product launches are expected to drive the segment's growth. For instance, in September 2022, Xenocor received US FDA approval for the enhanced version of its saberscope, a single-use laparoscope. In another instance, in November 2021, Shanghai MicroPort MedBot (Group) Co. Ltd launched DFVision 3D electronic laparoscope.
Bariatric or weight loss surgery is one of the significant laparoscopic procedures for treating obesity. During this procedure, the stomach size is reduced by removing some parts of the stomach or using a gastric band. Increasing obesity rates among children and adolescents are witnessed worldwide, leading to several young patients undergoing bariatric surgery. The increasing number of bariatric surgical procedures will likely raise the demand for laparoscopic devices. For instance, as per the WHO, in 2021, obesity had almost increased three-fold since 1975. In the 5–19 age bracket, obesity increased from less than 1% to 7% over the same period. According to the CDC, from 1999 through March 2020, the prevalence of obesity in the United States increased from 30.5% to 41.9%. During the same period, the prevalence of severe obesity increased from 4.7% to 9.2%.
Thus, the country's high prevalence of obesity is anticipated to drive the growth of bariatric surgery, thus driving the segment's growth.
To understand key trends, Download Sample Report
Cardiology is Expected to have a Significant Share in the Market
There is an increasing burden of cardiovascular diseases in the United States. According to a CDC report updated in October 2022, in the United States, about 20.1 million adults aged 20 years and above have coronary artery disease, accounting for about 7.2%. Furthermore, according to the same source, approximately 805,000 people in the United States have a heart attack yearly. As per the New York State Department of Health, an estimated 7.3% of adults in New York State reported they had angina/coronary heart disease, heart attack, or stroke in 2020. Furthermore, according to the same source, about 18.9% of the New York population aged 65 and older reported having some cardiovascular disease in 2020.
There are several types of cardiology surgeries, including CABG, insertion of a pacemaker or an implantable cardioverter defibrillator (ICD), heart valve repair or replacement, maze surgery, aneurysm repair, heart transplant, insertion of a ventricular assist device (VAD) or total artificial heart (TAH), and transcatheter structural heart surgery, among others. In recent years, significant progress has been made in developing and adopting minimally invasive techniques in cardiac surgery. For instance, in February 2021, Orlando Health, a network of community and specialty hospitals based in Orlando, Florida, launched a robotic cardiac surgery program providing robotic-assisted surgery for structural and valve diseases.
Thus, the country's high prevalence of cardiology diseases increases the demand for minimally invasive surgeries, which will likely drive the United States general surgical devices market.
US General Surgical Devices Industry Overview
The United States general surgical devices market is fragmented and competitive due to the presence of several major players operating globally. Some of the companies currently dominating the market are B. Braun SE, Boston Scientific Corporation, Cadence Inc., Conmed Corporation, Applied Medical Resources Corporation, Johnson & Johnson, Gettige AB, Medtronic PLC, Olympus Corporation, and Stryker Corporation, among others.
US General Surgical Devices Market Leaders
B. Braun Melsungen AG
Boston Scientific Corporation
Johnson & Johnson
*Disclaimer: Major Players sorted in no particular order
US General Surgical Devices Market News
- September 2022: Olympus Corporation launched THUNDERBEAT Open Fine Jaw Type X surgical energy devices for open surgery.
- April 2022: Johnson & Johnson (Ethicon) launched Enseal X1 Straight Jaw Tissue Sealer, a new advanced bipolar energy device. The ENSEAL X1 Straight Jaw is indicated for use in open and laparoscopic general, gynecological, urologic, thoracic, and ENT surgical procedures or any procedure where vessel ligation, tissue grasping, dissection, division of vessels, lymphatics, or tissue bundles is performed.
US General Surgical Devices Market Report - Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally Invasive Devices
4.2.2 Growing Cases of Injuries and Accidents
4.3 Market Restraints
4.3.1 Stringent Government Regulations
4.3.2 Improper Reimbursement for Surgical Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product
5.1.1 Handheld Devices
5.1.2 Laparoscopic Devices
5.1.3 Electro Surgical Devices
5.1.4 Wound Closure Devices
5.1.5 Trocars and Access Devices
5.1.6 Other Products
5.2 By Application
5.2.1 Gynecology and Urology
5.2.5 Other Applications
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun SE
6.1.2 Boston Scientific Corporation
6.1.3 Cadence Inc.
6.1.4 Conmed Corporation
6.1.5 Applied Medical Resources Corporation
6.1.6 Johnson & Johnson
6.1.7 Getinge AB
6.1.8 Medtronic PLC
6.1.9 Olympus Corporations
6.1.10 Stryker Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
US General Surgical Devices Market Research FAQs
What is the current United States General Surgical Devices Market size?
The United States General Surgical Devices Market is projected to register a CAGR of 6.1% during the forecast period (2023-2028).
Who are the key players in United States General Surgical Devices Market?
B. Braun Melsungen AG, Boston Scientific Corporation, Cadence Inc, Conmed Corporation and Johnson & Johnson are the major companies operating in the United States General Surgical Devices Market.
United States General Surgical Devices Industry Report
Statistics for the 2023 United States General Surgical Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. United States General Surgical Devices analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.